tiprankstipranks
Sarepta Therapeutics (SRPT)
NASDAQ:SRPT
Holding SRPT?
Track your performance easily

Sarepta Therapeutics (SRPT) Financial Statements

3,033 Followers

Sarepta Therapeutics Financial Overview

Sarepta Therapeutics's market cap is currently ―. The company's EPS TTM is $1.203; its P/E ratio is 97.89; Sarepta Therapeutics is scheduled to report earnings on March 4, 2025, and the estimated EPS forecast is $1.53. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Dec 23Sep 23
Income Statement-
Total Revenue$ 467.17M$ 362.93M$ 413.46M$ 396.78M$ 331.82M
Gross Profit$ 467.17M$ 362.93M$ 413.46M$ 352.61M$ 294.79M
EBIT$ 39.21M$ 18.76M$ 45.61M$ 45.60M$ -27.95M
EBITDA$ 49.02M$ 27.48M$ 54.36M$ 56.98M$ -17.02M
Net Income Common Stockholders$ 33.61M$ 6.46M$ 36.12M$ 45.66M$ -40.94M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 1.20B$ 1.46B$ 1.39B$ 1.68B$ 1.73B
Total Assets$ 3.60B$ 3.42B$ 3.22B$ 3.26B$ 3.11B
Total Debt$ 1.40B$ 1.37B$ 1.38B$ 1.40B$ 1.37B
Net Debt$ 199.13M$ -90.61M$ -11.44M$ -279.39M$ -362.02M
Total Liabilities$ 2.38B$ 2.35B$ 2.26B$ 2.41B$ 2.35B
Stockholders Equity$ 1.22B$ 1.08B$ 961.19M$ 859.34M$ 764.36M
Cash Flow-
Free Cash Flow$ -107.96M$ -14.22M$ -284.52M$ -73.70M$ -155.62M
Operating Cash Flow$ -70.70M$ 14.94M$ -242.08M$ -54.66M$ -114.71M
Investing Cash Flow$ -128.82M$ -98.53M$ 218.80M$ -64.36M$ -210.57M
Financing Cash Flow$ 13.76M$ 39.92M$ 22.14M$ 1.94M$ 15.40M
Currency in USD

Sarepta Therapeutics Earnings and Revenue History

Sarepta Therapeutics Debt to Assets

Sarepta Therapeutics Cash Flow

Sarepta Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis